Retapamulin
Back to searchMolecule Structure
Scientific Name
Retapamulin
Description of the Drug
Retapamulin is a topical antibiotic agent used for the treatment of impetigo caused by methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01256
http://www.drugbank.ca/drugs/DB01256
Brand Name(s)
Aitabax, Altabax, Altargo
Company Owner(s)
Almirall Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2364096 |
| 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2364103 |
Clinical Trial(s)
Unichem Links
| DrugBank | DB01256 | |
| PubChem: Thomson Pharma | 16578667 | |
| Nikkaji | J2.330.595J | |
| PDBe | G34 | |
| DrugCentral | 2371 | |
| rxnorm | RETAPAMULIN | ALTABAX |
| PubChem: Drugs of the Future | 12015312 | |
| ZINC | ZINC000100013500 |
